Fig. 2: Cumulative incidence curves of all-grade and severe immune checkpoint inhibitor-mediated colitis by polygenic risk score of ulcerative colitis in the GeRI cohort.
From: Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis
Cumulative incidence curves of a All-grade immune checkpoint inhibitor-mediated colitis (IMC) and b Severe IMC by categories of polygenic risk score of ulcerative colitis (PRSUC) in the entire GeRI cohort. Cumulative incidence curves are unadjusted, and PRSUC is categorized as ≤10th percentile (low genetic risk), 10–90th percentile (average genetic risk), and >90th percentile (high genetic risk). The p-values included on each plot are the results of a log-rank test for the difference between the curves (two-sided). Underneath each set of curves is the number of study participants at risk beyond that time point for each of the PRS groups. Source data are provided as a Source Data file.
